The Report Global Cephalosporin Drugs Market 2015-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants

Albany, NY -- (SBWire) -- 09/29/2015 --Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar activities to those of ampicillin. They are sometimes grouped into "generations" by their antimicrobial properties. Cephalosporin drugs can be grouped into five classes or generations. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin.

The Global Cephalosporin Drugs Market to grow at a CAGR of 3.21% over the period 2014-2019.

Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global cephalosporin drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/376547

Technavio's report, Global Cephalosporin Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cephalosporin drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
Americas
APAC
EMEA

Key vendors
Allergan
Astellas
Bristol-Myers Squibb
GlaxoSmithKline
Merck
Pfizer
Sandoz
Teva Pharmaceuticals

Other prominent vendors
Abbott
Aspen Pharmacare
AstraZeneca
Aurobindo Pharma
Basilea Pharmaceuticals
Baxter
Biocon
Corden Pharma
Cornerstone Therapeutics
Eli Lilly
F. Hoffmann-La Roche
Flynn Pharma
Hospira
Incepta Pharmaceuticals
Johnson & Johnson
Kyorin Pharmaceutical
Lupin Pharmaceuticals
Orchid Pharma
Par Pharmaceutical
Pernix Therapeutics
Sanofi
Shionogi
Sun Pharmaceutical
Takeda Pharma
Theravance Biopharma
Wockhardt

Market driver
Special regulatory designation for pipeline molecules
For a full, detailed list, view our report

Explore All Pharmaceutical Market Research Reports at http://www.marketresearchreports.biz/category/38

Market challenge
Development of drug resistance
For a full, detailed list, view our report

Market trend
Use of combination therapies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profiles in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, MarketResearchReports.biz has built a veritable reputation for fulfilling the most exacting market research needs.

Contacts
MarketResearchReports.biz
Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@marketresearchreports.biz
http://www.marketresearchreports.biz